Bakkt Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
Bakkt Holdings, Inc. filed a Form 8-K reporting an accounting error related to the historical financial statements of VPC Acquisition Impact Holdings (“VIH”), the SPAC that completed the merger with Legacy Bakkt. The report date was November 19, 2021; the filing was signed on November 22, 2021.
Financial Reporting Issue and Key Metrics
- Management identified an error in VIH’s application of ASC 480-10-S99-3A concerning the classification of Class A ordinary shares issued in VIH’s initial public offering.
- A portion of the shares subject to possible redemption had been misclassified between temporary equity and permanent equity.
- The filing does not provide a clear quantified amount for the resulting financial statement adjustments.
- Legacy Bakkt’s historical consolidated financial statements were not affected by the misclassification.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.
Material Changes Versus Prior Reporting
Management and the Audit Committee concluded that VIH’s previously issued financial statements for the year ended December 31, 2020, and the quarters ended March 31, June 30, and September 30, 2021, should no longer be relied upon. The company intends to restate certain condensed consolidated financial statements for those periods.
The affected statements were included in VIH’s Form 10-K filed March 31, 2021, and Forms 10-Q filed May 24, August 13, and October 13, 2021. VIH had previously recorded a reclassification adjustment without restating the historical statements because it considered the effect immaterial; the company subsequently determined that restatement was appropriate.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The filing provides no financial guidance or operating outlook.
- The accounting conclusion followed discussions with WithumSmith+Brown, VIH’s former independent registered public accounting firm, including discussions concerning evolving SEC staff positions and broader SPAC accounting issues.
- The restatement may affect previously reported equity classifications, additional paid-in capital, accumulated deficit, and Class A ordinary shares, but the filing does not state the final amounts.
- Current Bakkt management and its Audit Committee were not involved in VIH’s prior accounting and financial reporting determinations.
- Because VIH was determined to be the accounting acquirer, VIH’s historical financial statements continued as the historical financial statements of the combined company after the merger.
Important Facts for Investors to Verify
- Read the forthcoming restated financial statements and any related amendments to VIH/Bakkt filings.
- Verify the quantified impact on temporary equity, permanent equity, additional paid-in capital, accumulated deficit, and redeemable shares.
- Confirm whether the restatement affects any previously reported per-share data, balance-sheet totals, or covenant calculations.
- Review any updated auditor disclosures, internal-control conclusions, or additional SEC correspondence.
- Determine whether the accounting issue has any effect on Bakkt’s current liquidity, capitalization, or ability to execute its business plans.